Tao Synergies Inc (TAOX)

• Market cap: $37.1M
• 1 day: 10.94%
• 5 days: 20.05%
• 1 month: -18.52%
• 3 months: 3.33%
• 6 months: -31.26%
• Year to date: 12.19%
• 1 year: 134.43%
• 5 years: -97.1%
• 10 years: -97.1%
• Sector: Technology
• Industry: Software - Infrastructure

About: TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

Employees: 4